Execute a pivotal program for potential best-in-class BTK degrader, bexobrutideg, including Phase 2 and confirmatory Phase 3 studies to support ...

The notification removes “syrups … for cough” from Schedule K — the list of medicines exempted from the requirement of a ...

LISLE, IL, UNITED STATES, January 12, 2026 /EINPresswire.com/ -- OWP Pharmaceuticals today announced commercial product ...

The Radio 2 DJ has been using the Dr.Vegan blend for years and says it's the best women's multivitamin she's ever tried ...

NPPA fixed prices of 37 new drug formulations under DPCO 2013, covering diabetes, hypertension, respiratory and mental health medicines, to ensure affordable access and curb overcharging.

The Union Health Ministry has prohibited manufacture and sale of oral nimesulide formulations above 100 mg for human use, citing liver toxicity risks and acting on ICMR and DTAB recommendations ...

Novo Nordisk announced the availability of Wegovy tablets, the first oral GLP-1 receptor agonist for weight loss and CV risk reduction.

The launch of an oral semaglutide pill approved for weight loss represents a new frontier for GLP-1 drugs. Katie Rosseinsky ...

The KaiNETIC global Phase 3 clinical program includes three global, double-blind, randomized, placebo-controlled Phase 3 trials (KaiNETIC-1, KaiNETIC-2, and KaiNETIC-3) to evaluate weekly ribupatide ...

Dong-A Pharmaceutical Co. said on the 23rd that it has rolled out the German multivitamin brand "Orthomol Immun" at convenience stores including CU and GS25. Dong-A Pharmaceutical Co. has been ...

Patients with hereditary angioedema using deucrictibant as an on-demand treatment for attacks achieved onset of symptom ...